Ferulic Acid

CAS No. 1135-24-6

Ferulic Acid( Coniferic Acid | 4-hydroxy-3-Methoxycinnamic Acid | NSC 2821 | NSC 51986 | NSC 674320 )

Catalog No. M10474 CAS No. 1135-24-6

Ferulic Acid is a hydroxycinnamic acid and a type of organic compound found in the Ferula assafoetida L. or Ligusticum chuanxiong.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 27 In Stock
100MG 41 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ferulic Acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Ferulic Acid is a hydroxycinnamic acid and a type of organic compound found in the Ferula assafoetida L. or Ligusticum chuanxiong.
  • Description
    Ferulic Acid is a hydroxycinnamic acid and a type of organic compound found in the Ferula assafoetida L. or Ligusticum chuanxiong.(In Vitro):Ferulic acid (FA) is a novel fibroblast growth factor receptor 1 (FGFR1) inhibitor with IC50s of 3.78 and 12.5 μM for FGFR1 and FGFR2, respectively. Ferulic acid exhibits great inhibitory activity on FGFR1 with an inhibitory rate of 92% at 1 μM. The proliferation of HUVEC stimulated by FGF1 is markedly decreased after Ferulic acid treatment ranging from 5 to 40 μM for 24 h. Ferulic acid does not exert significant cell viability up to 20 μM, but over 30 μM Ferulic acid exhibits a cytotoxic effect in HUVEC compare to the control. Ferulic acid inhibits FGF1-induced HUVEC migration and invasion in a dose-dependent manner. Ferulic acid markedly suppresses the FGF1-induced phosphorylation of PI3K and Akt. Ferulic acid treatments significantly inhibit MMP-2 and MMP-9 expression stimulated by FGF1. (In Vivo):Treatment with Ferulic acid (FA) potently inhibits FGF1-induced neovascularization. It is found that intragastric administration of Ferulic acid markedly inhibits tumor volume and tumor weight, as compare to the counterparts treated with DMSO. Furthermore, Ferulic acid treatment is well tolerated, and there is no significant difference in weight between the vehicle group and the FA-treated groups. Ferulic acid (0.01, 0.1, 1 or 10 mg/kg) given by oral route decreases significantly the immobility time in the forced swimming test (FST) and tail suspension test (TST), whereas produces no effect in the open-field test. Results demonstrate that the administration of Ferulic acid (0.001 mg/kg, p.o.) boosts the antidepressant-like effect of fluoxetine (5 mg/kg, p.o.) in the TST.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Coniferic Acid | 4-hydroxy-3-Methoxycinnamic Acid | NSC 2821 | NSC 51986 | NSC 674320
  • Pathway
    Angiogenesis
  • Target
    FGFR
  • Recptor
    FGFR1
  • Research Area
    Other Indications
  • Indication
    ——

Chemical Information

  • CAS Number
    1135-24-6
  • Formula Weight
    194.19
  • Molecular Formula
    C10H10O4
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 39 mg/mL (200.83 mM); DMSO: 39 mg/mL (200.83 mM)
  • SMILES
    O=C(O)/C=C/C1=CC=C(O)C(OC)=C1
  • Chemical Name
    (E)-3-(4-hydroxy-3-methoxyphenyl)acrylic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Yang GW, et al. Int J Mol Sci. 2015 Oct 12;16(10):24011-3
molnova catalog
related products
  • BLU9931

    BLU9931 (BLU-9931) is a potent, selective, irreversible inhibitor of FGFR4 with IC50 of 3 nM.

  • AZD4547

    A potent and selective inhibitor of FGFR1/2/3 with IC50s of 0.2/1.8/2.5 nM.

  • Infigratinib

    Infigratinib (NVP-BGJ398, BGJ398) is a potent, selective pan-FGFR inhibitor.